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Fresh clinical isolatesa b s t r a c t
Trichomonas vaginalis is the causative agent of trichomonosis, the most common non-viral sexually trans-
mitted disease. Infection with this protozoan may have serious consequences, especially for women.
Currently, 5-nitroimidazole drugs are the treatment of choice for trichomonosis, but the emergence of
resistance has limited the effectiveness of this therapy. In this context, this study aimed to evaluate
the anti-T. vaginalis activity of marine-associated fungi found in the South Brazilian Coast. A total of 42
marine-associated fungal species (126 ﬁltrate samples) isolated from 39 different marine organisms,
mainly sponges, were selected to be screened against T. vaginalis. Of these, two ﬁltrate samples from Hyp-
ocrea lixii F02 and Penicillium citrinum F40 showed signiﬁcant growth-inhibitory activity (up to 100%)
against ATCC 30236 and fresh clinical isolates, including a metronidazole-resistant isolate. Minimum
inhibitory concentration (MIC) values of H. lixii F02 and P. citrinum F40 samples for all isolates tested,
including the metronidazole-resistant isolate, were 2.5 mg/mL. The kinetic growth curve showed that
the ﬁltrate samples were able to reduce the density of parasites to zero within 24 h of incubation, which
was conﬁrmed by microscopy. Both fungal ﬁltrate samples exhibited no hemolytic activity, and the P.
citrinum F40 ﬁltrate sample showed low cytotoxicity against Vero cells. These data suggest that
marine-associated fungi from the South Brazilian Coast may produce potential candidates for further
investigation and possible use in the treatment of metronidazole-resistant trichomonosis.
 2012 Elsevier Inc. Open access under the Elsevier OA license.er OA license. 
212 M. Scopel et al. / Experimental Parasitology 133 (2013) 211–2161. Introduction
Tricomonosis is a sexually transmitted disease (STD) caused by
the protozoan parasite Trichomonas vaginalis. The spectrum of
clinical presentation ranges from mildly symptomatic or totally
asymptomatic, especially in men, to severe vaginitis with abundant
vaginal discharge and cervicitis in women (Gilbert et al., 2000).
Trichomonosis is the most common non-viral STD worldwide
(WHO, 2001), and infection with this protozoan may lead to seri-
ous health complications, such as infertility (Cudmore and Garber,
2010), preterm delivery, low birth weight (Goldstein et al., 1993;
Cotch et al., 1997), and cervical cancer (Viikki et al., 2000).
Moreover, there is a strong association between human immuno-
deﬁciency virus (HIV) acquisition and T. vaginalis infection (van
der Pol et al., 2008; Mayer et al., 2012).
Globally, the number of new trichomonosis cases is estimated
to be 174 million per year (WHO, 2001), and 5-nitroimidazole
drugs are recommended as the treatment of choice for this STD
(Helms et al., 2008). However, treatment with these drugs is lim-
ited due to the increasing number of documented T. vaginalis-resis-
tant isolates (Blaha et al., 2006; Upcroft et al., 2009; Krashin et al.,
2010). Drug resistance poses major challenges to the management
of infection, particularly with the paucity of new drugs with
activity against this protozoan. This prompted us to investigate
marine-associated fungi from the South Brazilian Coast as new
alternatives to 5-nitroimidazole drugs currently used in the
treatment of T. vaginalis infection.
Unlike investigations of well-known protozoan parasites, such
as the causative agents of malaria, schistosomosis, Chagas disease,
onchocercosis, leishmaniosis, and African trypanosomosis, re-
search on natural products with antitrichomonal activity is rarely
found in the literature. Anti-Trichomonas activity has been de-
scribed in studies on marine organisms (Gehrig and Efferth,
2009; Watts et al., 2010), such as algae (Moo-Puc et al., 2008; Can-
tillo-Ciau et al., 2010; Machado et al., 2010), and on marine micro-
organisms, such as dinoﬂagellate Amphidinium sp. (Washida et al.,
2006), but no study has speciﬁcally examined antitrichomonal
activity in marine fungi.
Several biological activities of marine microorganisms have
been described, such as antibioﬁlm, antimicrobial, antitumor, anti-
viral, antioxidant, and anti-inﬂammatory activities, as well as cell
cycle and phosphatase/kinase inhibition (Mayer and Hamann,
2005; Blunt et al., 2007; Scopel et al., unpublished results). In addi-
tion, some metabolites from marine-derived fungi have been re-
ported to have antiprotozoal activities against Trypanosoma cruzi
and T. brucei, Plasmodium falciparum (Kasettrathat et al., 2008; Pon-
tius et al., 2008; Watts et al., 2010), and other protozoa. However,
to our knowledge, there is as yet no study examining antitricho-
monal activity in marine-associated fungi from the South Brazilian
Coast.
Given the need for new antiprotozoal therapies and the emerg-
ing importance of marine-associated fungi as a source of bioactive
molecules, this study aimed to evaluate the anti-T. vaginalis
activity of marine-associated fungal species isolated from different
marine organisms, mainly sponges, found in the South Brazilian
Coast.2. Materials and methods
2.1. Fungal isolates and cultivation
Forty-two marine-associated fungi were isolated from 39 mar-
ine organisms, which were obtained from the Arvoredo Island in
the Arvoredo Biological Marine Reserve (27S 160 42.400/48W 22030.800/Santa Catarina state, Brazil) in November, 2007. All fungal
strains were identiﬁed and the sequences were deposited in
DDBJ/EMBL/GenBank under the accession numbers HE608773 to
HE608809, as indicated in Table 1. The 42 isolates were grown
on Sabouraud agar at 25 C for 7 days. Three agar plugs (8 mm in
diameter) of each strain were used to inoculate 250-mL ﬂasks
containing 50 mL of Sabouraud broth. Each strain was cultivated
at 25 C under static conditions for 7, 14, and 21 days. After each
period, the strains were ﬁltered under vacuum through ﬁlter paper
on a Buchner funnel to separate the culture ﬁltrate from the myce-
lium. The ﬁltrate was ﬁltered through a 0.22-lm sterile membrane
and kept frozen until use.2.2. T. vaginalis cultivation
The organisms used in this study included one isolate from the
American Type Culture Collection (ATCC), 30236, and two fresh
clinical isolates, TV-LACH1 and TV-LACM2 (metronidazole-sensi-
tive and -resistant strains). The fresh clinical isolates were
obtained from Laboratório de Análises Clínicas e Toxicológicas,
Faculdade de Farmácia, UFRGS, Brazil (project approved by UFRGS
Research and Ethics Committee, protocol number 18923). Tricho-
monads were cultured axenically in vitro in a trypticase–yeast ex-
tract–maltose (TYM) medium (pH 6.0), supplemented with 10%
heat-inactivated bovine serum (HIBS [v/v]), and incubated at
37 C (±0.5) (Diamond, 1957). Organisms exhibiting motility and
normal morphology during the logarithmic growth phase were
harvested, centrifuged, washed three times with phosphate-buf-
fered saline 1x (PBS) (pH 7.0), and resuspended in new TYM med-
ium. All experiments were performed in triplicate with at least
three independent cultures (n = 3).2.3. Anti-T. vaginalis screening
A total of 126 ﬁltrates from marine-associated fungi were
screened against T. vaginalis trophozoites (ATCC 30236). The assay
was performed using 96-well microtiter plates with TYM medium,
ﬁltrate at a concentration of 2.5 mg/mL, and an initial inoculum of
2.5  105 trophozoite per mL, giving a ﬁnal volume of 200 lL. After
24 h of incubation at 37 C (±0.5), the number of viable trophozo-
ites was measured using the quantitative resazurin method as pre-
viously described by Duarte et al. (2009). The interpretation of
motility and normal morphology was conﬁrmed by manual
microscopy, and the viability of trophozoites was characterized
using trypan blue dye exclusion (0.2% [v/v]). In control cultures,
fungal ﬁltrate samples were replaced with water.2.4. Minimum inhibitory concentration (MIC)
First, the MIC value against T. vaginalis (ATCC 30236) was deter-
mined using only the fungal ﬁltrate samples that reduced under
50% the parasite viability in the initial screening. MIC was estab-
lished in 96-well microtiter plates containing TYM medium and
an initial inoculum of 2.5  105 trophozoites per mL. The concen-
tration of ﬁltrate samples was obtained by serial dilution within
the range of 20–0.156 mg/mL (Frasson et al., 2011). After 24 h of
incubation at 37 C (±0.5), trophozoite viability was evaluated
using the quantitative resazurin method (Duarte et al., 2009). Then,
only the fungal ﬁltrate samples that produced the lowest MIC val-
ues, which were considered active ﬁltrate samples, were tested
against fresh clinical isolates of T. vaginalis. These active fungal ﬁl-
trate samples were used in the subsequent experiments.
Table 1
Species from the marine associated fungi screened against T. vaginalis ATCC 30236; (%) viability represents the percentage of living organisms compared to control parasites,
considering the amount of resazurin reduced by viable T. vaginalis.
Supernatant code Fungal strain (BLAST similarity/assecion number) Culture days
7 days 14 days 21 days
Viability (%) Viability (%) Viability (%)
Control 100 100 100
SBa 95.25 96.05 161.56
F01 Westerdykella purpurea (HE608773) 88.46 112.02 141.85
F02 Hypocrea lixii (HE608774) 97.91 102.42 0
F03 Calonectria canadense (HE608775) 184.17 91.66 163.60
F04 Penicillium citrinum (HE608776) 73.86 102.08 132.11
F05 Ascomycete class (HE608777) 84.24 117.01 104.83
F06 Penicillium sp. (HE608778) 105.43 112.02 133.24
F07 Unknown 31.48 102.42 124.62
F08 Dothideomycete class (HE608779) 200.15 92.90 N.D.
F10 Cladosporium sp. (HE608780) 83.80 104.51 124.54
F11 Cladosporium cladosporioides (HE608781) 135.78 138.51 130.98
F12 Polyporus sp. (HE608782) 134.74 159.46 61.31
F13 Penicillium corylophilum (HE608783) 67.26 144.78 132.92
F14 Cladosporium sp. (HE608784) 137.67 97.57 142.73
F15 Ramichloridium apiculatum (HE608785) 121.73 126.70 95.65
F16 Ascomycete class (HE608786) 83.00 94.11 106.91
F17 Cladosporium cladosporioides (HE608787) 126.76 106.39 88.94
F18 Westerdykella sp. (HE608788) 105.30 79.21 97.67
F19 Penicillium daleae (HE608789) 89.11 88.32 77.16
F20 Eutypella leprosa (HE608790) 188.20 105.57 91.45
F21 Simplicillium lanosoniveum (HE608791) 352.84 226.93 44.43
F22 Sordariales order (HE608792) 185.88 170.14 83.00
F23 Unknown 57.81 90.54 35.96
F24 Cladosporium cladosporioides. (HE608793) 67.03 148.40 59.64
F25 Phoma sp. (HE608794) 72.39 N.D. 92.71
F26 Phoma sp. (HE608795) 53.40 283.60 84.19
F27 Rhinocladiella sp. (HE608796) 51.65 N.D. 147.65
F28 Pestalosphaeria hansenii (HE608797) 82.43 339.99 103.40
F29 Alternaria alternata. (HE608798) 133.68 196.12 182.04
F30 Westerdykella purpurea (HE608799) 173.91 347.25 184.10
F32 Unknown 132.89 257.84 43.43
F33 Xylariales order (HE608800) 95.56 170.85 132.18
F34 Unknown 92.40 258.55 128.20
F35 Phoma sp. (HE608801) 140.07 198.11 N.D.
F36 Aspergillus versicolor. (HE608802) 89.61 N.D. 121.52
F37 Penicillium sp. (HE608803) 165.79 187.36 57.71
F38 Nigrospora oryzae (HE608804) 105.95 156.29 N.D.
F39 Unknown 141.84 46.53 53.48
F40 Penicillium citrinum (HE608805) 166.16 0 53.01
F41 Xylariales order (HE608806) 107.20 N.D. 100.86
F42 Aspergillus versicolor (HE608808) 104.39 32.00 235.52
F43 Aspergillus oryzae (HE608808) 139.13 16.07 131.37
F44 Penicillium sp. (HE608809) 117.01 43.09 218.75
a SB, sabouraud broth without fungi growth; N.D., not determined.
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Kinetic growth experiments were performed using the ATCC
30236 isolate and fungal ﬁltrate samples at MIC treated and not
treated by heating (autoclaving at 121 C for 20 min). For these
experiments, an initial inoculum of 2.5  105 trophozoites per mL
was grown in TYM medium (1.5 mL ﬁnal volume), using micro-
tubes. Parasites were counted using a hemocytometer during
72 h (at 0, 2, 4, 6, 12, 24, 48, and 72 h). Trophozoites were
characterized considering motility, normal morphology, and try-
pan blue dye exclusion (0.2% [v/v]). The results were expressed
as the number of living organisms compared to that of untreated
parasites.
2.6. Hemolytic assay
This assay was performed according to Gauthier et al. (2009),
with modiﬁcations. Fresh human blood was obtained from healthy
voluntary donors, collected in Alsever’s solution (1:1 [v/v]). The
erythrocytes were washed three times with PBS 1x andresuspended to obtain an erythrocyte suspension (1.0% [v/v]).
The erythrocytes were incubated with the fungal ﬁltrate samples
at MIC on a shaker at 37 C for 60 min. Filtrate absorbance was
measured at 540 nm. The percentage of hemolysis induced by each
sample was calculated using commercial fractions containing Quil-
laja saponaria saponins (S5) as a reference for 100% hemolysis (po-
sitive control) (Sun et al., 2008). Erythrocytes incubated with PBS
were used as negative controls. The hemolytic assay was per-
formed in triplicate on three independent experiments (n = 3).
2.7. Cytotoxicity against Vero cells
Vero cells were grown and maintained in Dulbecco’s modiﬁed
Eagle’s medium (DMEM), supplemented with 10% fetal bovine ser-
um (FBS) at 37 C and 5% CO2. For this assay, 1.5  104 cells per
well were seeded in 96-well microtiter plates for 24 h. After this
period, the medium was replaced with fresh medium containing
or not (control condition) fungal ﬁltrate samples at MIC. A solution
containing 1% Triton was added as a positive control. The plates
were incubated for 24 h, and then, after one wash with PBS, a
Table 3
Hemolytic effect of F02 and F40 marine associated fungi ﬁltrate.
Samples % Hemolysisa
Positive control (Q. saponaria) 100 ± 0
Negative control 1.6 ± 0.44
F02 (2.5 mg mL1) 9.3 ± 0.03
F40 (2.5 mg mL1) 2.61 ± 0.33
a The values represent the mean ± standard deviation.
Table 2
Minimum inhibitory concentration (MIC) of marine associated fungi ﬁltrate for










F02 2.5 2.5 2.5
F07 >20 N.D. N.D.
F21 >20 N.D. N.D.
F23 >20 N.D. N.D.
F32 >20 N.D. N.D.
F39 >20 N.D. N.D.
F40 2.5 2.5 2.5
F42 >20 N.D. N.D.
F43 >20 N.D. N.D.
F44 >20 N.D. N.D.
N.D., not determined.
a Metronidazole-resistant isolate.
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mide) solution (0.5 mg/mL) was added to and kept in the wells
for 1 h. The plates were washed twice with PBS, and the insoluble
purple formazan was dissolved in dimethyl sulfoxide (DMSO). The
amount of reduced MTT was measured at 570 nm.
3. Results
In the present study we screened the anti-T. vaginalis activity of
126 ﬁltrate samples from 42 marine-associated fungi (Table 1).
This initial screening revealed that 10 ﬁltrate samples (F02- Hypo-
crea lixii, F07-Unknown, F21- Simplicillium lanosoniveum, F23-Un-
known, F32-Unknown, F39-Unknown, F40- Penicillium citrinum,
F42- Aspergillus versicolor, F43- Aspergillus oryzae, F44- Penicillium
sp.) were effective in reducing parasite viability by at least 50% (Ta-
ble 1). The 10 active samples were submitted to MIC assay, and
only two were more effective with low values of MIC (2.5 mg/
mL), while all others allowed trophozoite growth at concentrations
higher than 20 mg/mL (Table 2). Therefore, the subsequent exper-
imental procedures were performed using only these two ﬁltrate
samples: H. lixii F02 (21-day culture) and P. citrinum F40 (14-day
culture). Two different fresh clinical isolates of T. vaginalis were
tested, a metronidazole-sensitive (TV-LACH1) and a metronida-
zole-resistant (TV-LACM2) isolate. Both ﬁltrate samples (H. lixii
F02 and P. citrinum F40) were effective against these isolates and
had the same MIC value of 2.5 mg/mL (Table 2).
Fig. 1 shows the kinetic growth curve of the activity of H. lixii
F02 and P. citrinum F40 ﬁltrate samples against T. vaginalis tropho-
zoites. The ﬁltrate samples were able to completely inhibit parasiteFig. 1. Effect of H. lixii F02 and P. citrinum F40 ﬁltrate samples on the T. vaginalis (ATCC
growth was completely inhibited by both ﬁltrates within the ﬁrst hours of incubation
mean ± standard deviation of at least three experiments.growth after 24 h of incubation (Fig. 1). Conversely, as expected,
trophozoite growth from the control culture increased over the
incubation period, reaching the highest density in 24 h and
decreasing only after 72 h of incubation (Fig. 1). Heating reverted
the cytotoxic effect of P. citrinum F40 ﬁltrate, and parasite growth
was the same as that of the control. In contrast, the activity of H.
lixii F02 ﬁltrate sample was preserved after heating, although it
was less potent than the untreated sample (Fig. 1).
The hemolytic test, which allows predict the damage in cellular
membranes, was used to examine the potential effect of H. lixii F02
and P. citrinum F40 ﬁltrate samples upon mammalian cells. In Table
3 it can be observed that both ﬁltrate samples exhibited no hemo-
lytic activity. In addition, the viability of Vero cells was also evalu-
ated to examine the potential cytotoxicity of these fungal ﬁltrate
samples. While H. lixii F02 ﬁltrate sample showed high toxicity
against mammalian cells, P. citrinum F40 sample showed low cyto-
toxicity against Vero cells, with 79% of cell viability (Fig. 2).4. Discussion
Resistance of T. vaginalis to metronidazole has been reported to
reach up to 9% (Schwebke and Barrientes, 2006). Therefore, and
worryingly, in the absence of a non-nitroimidazole alternative to
treatment, cure can only be achieved by increasing doses of metro-
nidazole (Cudmore et al., 2004). However, higher doses lead to
adverse events severe enough to cause cessation of treatment
(Cudmore et al., 2004; Schwebke and Barrientes, 2006). Thus, our
efforts are now focused on exploring Brazil’s natural potential re-
sources to expand sources of novel therapeutic agents potentially
useful for treatment of T. vaginalis infection. Marine microorgan-
isms which colonize sponges are responsible for the stabilization
of the sponge skeleton and participate in the host’s chemical
defense system against predators, among other functions (Lee
et al., 2001). This chemical defense is mediated by the production
of secondary metabolites, which gives to these microorganisms
different abilities, such as antimicrobial, antifungal, antitumor,30236 isolate) kinetic growth curve (heat-treated and untreated samples). Parasite
, and heat treatment affected only the activity of P. citrinum F40. Data represent
Fig. 2. Effect of H. lixii F02 and P. citrinum F40 ﬁltrate samples on the viability of
Vero cells. While H. lixii F02 was highly cytotoxic, P. citrinum F40 was able to sustain
cell viability. Control represents Vero cells in DMEM medium, without samples.
Data represent mean ± standard deviation of at least three experiments.
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suggesting the property anti-T. vaginalis.
The initial screening revealed that most fungal ﬁltrates pro-
duced an increase in the number of trophozoites. This may occur
due to high glucose availability from Sabouraud broth, which has
20% of glucose in its composition. Kuile (1996) stated that the
enzymatic route of trichomonads involved in glucose metabolism
is stimulated in the presence of high glucose availability.
Among all ﬁltrate samples, only H. lixii F02, isolated from the
sponge Axinella corrugata and P. citrinum F40, isolated from the
sponge Stoeba sp., were effective in eliminating T. vaginalis tropho-
zoites at a low concentration (Table 2). Importantly, the ﬁltrates of
these two fungal species were effective against both ATCC 30236
and fresh clinical isolates, including the metronidazole-resistant
TV-LACM2. Moreover, the effect of H. lixii F02 and P. citrinum F40
ﬁltrates on the kinetic growth of T. vaginalis trophozoites could
be observed in the ﬁrst hours of incubation and within 24 h no
viable parasites could be detected (Fig. 1). The samples exhibited
different behaviors when treated by heating. P. citrinum F40 lost
its activity after heat treatment, probably because of the instability
of chemical constituents, while H. lixii F02 appeared to have ther-
mostable active compounds. These results indicate that there are
two possible different molecular entities capable of acting upon
T. vaginalis.
To our knowledge, this is the ﬁrst study to report an anti-T. vag-
inalis activity of H. lixii F02 and P. citrinum F40, although some
studies evaluating their biological activities have already been de-
scribed. Strains of the marine fungus P. citrinum have been shown
to produce a hemiacetal compound with cytotoxic activity against
the human promyelocytic leukemia (HL-60) cell line (Ni et al.,
2011). Tricitrinols also isolated from this specie have shown cyto-
toxicity and inhibited human topoisomerase IIa in different exper-
imental models (Du et al., 2011). P. citrinum may also be found in
soil samples, and antioxidant activity as well as antibacterial prop-
erties against Pseudomonas aeruginosa, Staphylococcus epidermidis,
and Enterococcus durans have been observed in in vitro assays
(Amagata et al., 2003; Castillo-Machalskis et al., 2007; Arora and
Chandra, 2011). Conversely, only a few studies have examined
the biological activities of H. lixii (Trichoderma harzianum). Isolated
metabolites of this fungus have been able to inhibit the soilborne
pathogens Sclerotium rolfsii, Rhizoctonia solani, and Fusarium oxy-
sporum (Choudary et al., 2007), and the molecule 6-n-pentyl-pyr-
one has been reported to have antifungal and antibacterial
activity (Tarus et al., 2003). Recently, the marine strain of H. lixii,
included in a screening study against methicillin-resistant Staphy-
lococcus aureus (MRSA), has exhibited strong anti-MRSA and anti-
cancer activities for Hep2 and MCF7 (Zhang et al., 2011; Bhimba
et al., 2012).
The hemolytic assay evaluated possible cytotoxic mechanisms
involving membrane damage. Our results showed that both H. lixii
F02 and P. citrinum F40 ﬁltrate samples had no hemolytic effect,suggesting that there were no toxic effects towards plasma mem-
branes, and both fungal ﬁltrate samples were found to be compat-
ible with red blood cells. Surprisingly, and in contrast to the results
of the hemolytic assay, the H. lixii ﬁltrate sample showed strong
cytotoxicity against Vero cells. A similar observation has already
been described for three metabolites, trichodenones A–C, produced
by the fungus H. lixii (Trichoderma harzianum), which exhibited sig-
niﬁcant cytotoxicity against cultured P388 cells (Amagata et al.,
2003). However, P. citrinum F40 ﬁltrate sample allowed the growth
and viability of cells, demonstrating low cytotoxicity against mam-
malian cells.
In a comparison with studies on Plasmodium, xanthones iso-
lated from the marine-derived fungus Chaetomium sp. have shown
antiprotozoal activity, although with pronounced cytotoxicity, and
the analysis of the mode of action has indicated that these mole-
cules are able to inhibit heme polymerization causing the death
of parasitic cells (Pontius et al., 2008). Another mode of action
against Plasmodium has been observed with the fungal metabolite
apicidin by the inhibition of histone deacetylase (HDAC) (Darkin-
Rattray et al., 1996).
In conclusion, our ﬁndings on H. lixii F02 and P. citrinum F40
indicate these metabolites as extremely promising alternatives
against T. vaginalis due to their high cytotoxicity veriﬁed in ATCC
and fresh clinical isolates. It is worth emphasizing that these two
fungal samples were also effective against a metronidazole-resis-
tant isolate and that P. citrinum F40 ﬁltrate had no hemolytic activ-
ity, exerting a low cytotoxic effect on mammalian cells. In this
sense, our ﬁndings warrant further studies with H. lixii F02 and
mainly P. citrinum F40 ﬁltrates, which appear to be promising tar-
gets in the ﬁeld of antiprotozoal metabolites for the development
of novel antitrichomonal drugs. Accordingly, our current research
efforts focus on the puriﬁcation and elucidation of active molecules
from these fungi for further testing against host vaginal epithelial
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